Medication info
Twincombi Tablet 80/5 mg

Twincombi Tablet 80/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
Biconvex oval double-coated tablets that are white to pale yellow and light blue.
Packaging
30 tablets (10 tablets/PTP x 3), 30 tablets/bottle
Approval status
Active

MFDS item code 201605851 · Approved 2016.09.30 · Insurance code 671806310

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to this medicine may be considered as follows. - 40/5mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5mg or telmisartan 40mg. - 80/5mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5mg or this medicine 40/5mg. - 40/10mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended that treatment be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section '3. Patients for whom this medicine should be administered with caution.') In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
Child dose
18 years of age or younger: The safety and efficacy of this medicine have not been established; therefore, its use is not recommended.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively lower blood pressure and assist in the management of hypertension in patients with essential hypertension who are not adequately controlled with monotherapy of Amlodipine or Telmisartan.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to this medicine may be considered as follows. - 40/5mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5mg or telmisartan 40mg. - 80/5mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5mg or this medicine 40/5mg. - 40/10mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended that treatment be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section '3. Patients for whom this medicine should be administered with caution.') In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.

Child dose

18 years of age or younger: The safety and efficacy of this medicine have not been established; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, especially during the second and third trimesters, and should not be used during pregnancy. If pregnancy is confirmed, this medication should be discontinued as soon as possible and replaced with another safe treatment if necessary. Patients with allergies to any components of this medication or those with specific heart, liver, or kidney diseases should avoid taking it. It is also recommended that breastfeeding women do not take this medication. This medication lowers blood pressure, so it should be used with caution in patients with hypotension or severe heart failure. Patients with impaired kidney function or those at risk of hyperkalemia should regularly monitor their serum potassium levels. Interactions may occur when taken with other blood pressure medications or certain drugs, so consultation with a healthcare provider or pharmacist is required. If unusual symptoms such as dizziness, swelling, or severe fatigue occur during treatment, immediate notification to a healthcare professional is necessary. Elderly patients should start on a lower dose and increase gradually for safety. In the case of overdose, hypotension, arrhythmias, and other symptoms may occur, and emergency treatment should be sought. This medication is not recommended for children and should be kept out of reach of children.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 102 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbances
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle hypertonia
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • polymorphic erythema
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • acute renal failure
  • urination disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • elevated blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light, so it should be stored in a container that protects it from light. Additionally, it is best to store the medication at a temperature between 1°C to 30°C at room temperature. Storing it this way will help maintain its effectiveness.

Appearance and packaging

Appearance

Biconvex oval double-coated tablets that are white to pale yellow and light blue.

Package unit

30 tablets (10 tablets/PTP x 3), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.